
Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
LONDON – A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior